| abstract |
In certain embodiments, the present disclosure provides nucleic acid compounds, compositions and methods that inhibit EphrinB2 or EphB4 expression. In certain embodiments, the present disclosure provides methods and compositions for treating cancer or treating angiogenesis-related diseases. |